ThePharmyard Click here to see all DOVE Medical Press titles in ThePharmYard
Pay-as-you-go medical and pharmaceutical industry information About Us | Contact Us | Terms
The Publishers

How should we measure medication adherence in clinical trials and practice?

This expert article was written by Jeannie K Lee and colleagues and first published in Therapeutics and Clinical Risk Management, Volume 3, Number 4, September 2007

Product Details - See below for further product information
Note the document you buy is licensed for your own use only.

File type and size: PDF 0.117 MB
Publication size: 10 pages
Publication date: September 2007
Published by: Dove Medical Press
ThePharmYard product code: dove345

Our Price: £20.00
You are buying an e-document. This is a digital product and therefore UK VAT @ 17.50 % will be added at Checkout if your billing address is in the EU.

Related Products:

People who purchased this also purchased...

Further Product Information

AUTHORS:

Jeannie K Lee, Karen A Grace, Terri G Foster, Monica J Crawley, Goldina I Erowele, Hazel J Sun, Phuong T Turner, Lance E Sullenberger and Allen J Taylor Pharmacy and Cardiology Services, Walter Reed Army Medical Center, Washington, DC, USA

ABSTRACT

Objective: To determine if simple adherence measures, such as twenty-four hour recall and refill history, are accurate for routine use, compared to more time-consuming measures such as pill counts.

Design: Randomized, double-blind, placebo-controlled trial.

Setting: Walter Reed Army Medical Center, a tertiary medical center in Washington.

Patients: Men and women >30 years old with known coronary heart disease and taking a statin medication.

Intervention: Clinical pharmacists met with patients for adherence assessments. Main outcome measures: Adherence was measured by pill counts, twenty-four hour recall by patient, and refill history per computer record. Temporal changes in these adherence measures were assessed using general linear models for repeated measures.

Results: Adherence was consistently greater for the experimental agent than for the statin therapy (n = 148). Mean pill count adherence for statin drug was 78.7 ± 25.2% compared to 93.5 ± 11.6% (P < 0.001) for the study agent. Refill history and twenty-four hour recall inaccurately measured adherence when compared to pill counts. Adherence, as determined by pill count, for both experimental (P = 0.029) and statin therapy (P = 0.015) showed significant variability across time in general linear models. Neither refill history nor twenty-four hour recall was sensitive to temporal changes.

Conclusions: Twenty-four hour recall and refill history inaccurately measure medication adherence for both clinical trial and clinical practice pharmacotherapies. Further, these measures are insensitive to changes in adherence. For a single or multiple assessments across time, pill count more accurately measures medication adherence. Pill count should be the standard for monitoring medication adherence for both clinical trials and clinical practice.



ABOUT THE JOURNAL

Therapeutics and Clinical Risk Management

ISSN 1176-6336

An international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines.

Affiliates | About Us | Contact Us | Terms

ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2010

Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePublicationPlan.com]

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo